aluates Reports

$ 0.0

Automative

Global Generic Medicine Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-15M5978

Global Generic Medicine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Generic Medicine Market Research Report 2025

Code: QYRE-Auto-15M5978

Report

July 2025

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

TEVA

Novartis (Sandoz)

Mylan NV

Sun Pharmaceutical

Aspen

Fresenius Kabi

Pfizer (Hospira)

Sanofi

Aurobindo

Lupin Ltd

Dr. Reddy's

Apotex

Cipla Ltd

ENDO (Par Pharmaceutical)

Stada Arzneimittel

Krka Group

Nichi-Iko Pharmaceutical

Valeant

Zydus Cadila

Hikma

Generic Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Generic Medicine Market

The global market for Generic Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Generic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Medicine.

The Generic Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Generic Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Generic Medicine Market Report

Report Metric	Details
Report Name	Generic Medicine Market
CAGR	5%
Segment by Type	Simple Generic Drugs Super Generic Drugs Biosimilars
By Application:	CNS Cardiovascular Respiratory Rheumatology Diabetes Oncology
Segment by Application	CNS Cardiovascular Respiratory Rheumatology Diabetes Oncology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi, Aurobindo, Lupin, Dr. Reddy's, Apotex, Cipla, ENDO (Par Pharmaceutical), Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Hikma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Generic Medicine Market report?

Ans: The main players in the Generic Medicine Market are Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi, Aurobindo, Lupin, Dr. Reddy's, Apotex, Cipla, ENDO (Par Pharmaceutical), Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Hikma

What are the Application segmentation covered in the Generic Medicine Market report?

Ans: The Applications covered in the Generic Medicine Market report are CNS, Cardiovascular, Respiratory, Rheumatology, Diabetes, Oncology, Others

What are the Type segmentation covered in the Generic Medicine Market report?

Ans: The Types covered in the Generic Medicine Market report are Simple Generic Drugs, Super Generic Drugs, Biosimilars

Recommended Reports

Generic Pharmaceuticals

Diagnostics & Testing

Therapeutics & Disease

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Generic Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Simple Generic Drugs

1.2.3 Super Generic Drugs

1.2.4 Biosimilars

1.2.5 By Application:

1.2.6 CNS

1.2.7 Cardiovascular

1.2.8 Respiratory

1.2.9 Rheumatology

1.2.10 Diabetes

1.3 Market by Application

1.3.1 Global Generic Medicine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 CNS

1.3.3 Cardiovascular

1.3.4 Respiratory

1.3.5 Rheumatology

1.3.6 Diabetes

1.3.7 Oncology

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Generic Medicine Market Perspective (2020-2031)

2.2 Global Generic Medicine Growth Trends by Region

2.2.1 Global Generic Medicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Generic Medicine Historic Market Size by Region (2020-2025)

2.2.3 Generic Medicine Forecasted Market Size by Region (2026-2031)

2.3 Generic Medicine Market Dynamics

2.3.1 Generic Medicine Industry Trends

2.3.2 Generic Medicine Market Drivers

2.3.3 Generic Medicine Market Challenges

2.3.4 Generic Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Generic Medicine Players by Revenue

3.1.1 Global Top Generic Medicine Players by Revenue (2020-2025)

3.1.2 Global Generic Medicine Revenue Market Share by Players (2020-2025)

3.2 Global Generic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Generic Medicine Revenue

3.4 Global Generic Medicine Market Concentration Ratio

3.4.1 Global Generic Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Generic Medicine Revenue in 2024

3.5 Global Key Players of Generic Medicine Head office and Area Served

3.6 Global Key Players of Generic Medicine, Product and Application

3.7 Global Key Players of Generic Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Medicine Breakdown Data by Type

4.1 Global Generic Medicine Historic Market Size by Type (2020-2025)

4.2 Global Generic Medicine Forecasted Market Size by Type (2026-2031)

5 Generic Medicine Breakdown Data by Application

5.1 Global Generic Medicine Historic Market Size by Application (2020-2025)

5.2 Global Generic Medicine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Generic Medicine Market Size (2020-2031)

6.2 North America Generic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Generic Medicine Market Size by Country (2020-2025)

6.4 North America Generic Medicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Generic Medicine Market Size (2020-2031)

7.2 Europe Generic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Generic Medicine Market Size by Country (2020-2025)

7.4 Europe Generic Medicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Generic Medicine Market Size (2020-2031)

8.2 Asia-Pacific Generic Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Generic Medicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Generic Medicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Generic Medicine Market Size (2020-2031)

9.2 Latin America Generic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Generic Medicine Market Size by Country (2020-2025)

9.4 Latin America Generic Medicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Generic Medicine Market Size (2020-2031)

10.2 Middle East & Africa Generic Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Generic Medicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Generic Medicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Details

11.1.2 Teva Business Overview

11.1.3 Teva Generic Medicine Introduction

11.1.4 Teva Revenue in Generic Medicine Business (2020-2025)

11.1.5 Teva Recent Development

11.2 Novartis - Sandoz

11.2.1 Novartis - Sandoz Company Details

11.2.2 Novartis - Sandoz Business Overview

11.2.3 Novartis - Sandoz Generic Medicine Introduction

11.2.4 Novartis - Sandoz Revenue in Generic Medicine Business (2020-2025)

11.2.5 Novartis - Sandoz Recent Development

11.3 Mylan

11.3.1 Mylan Company Details

11.3.2 Mylan Business Overview

11.3.3 Mylan Generic Medicine Introduction

11.3.4 Mylan Revenue in Generic Medicine Business (2020-2025)

11.3.5 Mylan Recent Development

11.4 Sun Pharmaceutical

11.4.1 Sun Pharmaceutical Company Details

11.4.2 Sun Pharmaceutical Business Overview

11.4.3 Sun Pharmaceutical Generic Medicine Introduction

11.4.4 Sun Pharmaceutical Revenue in Generic Medicine Business (2020-2025)

11.4.5 Sun Pharmaceutical Recent Development

11.5 Aspen

11.5.1 Aspen Company Details

11.5.2 Aspen Business Overview

11.5.3 Aspen Generic Medicine Introduction

11.5.4 Aspen Revenue in Generic Medicine Business (2020-2025)

11.5.5 Aspen Recent Development

11.6 Fresenius Kabi

11.6.1 Fresenius Kabi Company Details

11.6.2 Fresenius Kabi Business Overview

11.6.3 Fresenius Kabi Generic Medicine Introduction

11.6.4 Fresenius Kabi Revenue in Generic Medicine Business (2020-2025)

11.6.5 Fresenius Kabi Recent Development

11.7 Pfizer (Hospira)

11.7.1 Pfizer (Hospira) Company Details

11.7.2 Pfizer (Hospira) Business Overview

11.7.3 Pfizer (Hospira) Generic Medicine Introduction

11.7.4 Pfizer (Hospira) Revenue in Generic Medicine Business (2020-2025)

11.7.5 Pfizer (Hospira) Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Generic Medicine Introduction

11.8.4 Sanofi Revenue in Generic Medicine Business (2020-2025)

11.8.5 Sanofi Recent Development

11.9 Aurobindo

11.9.1 Aurobindo Company Details

11.9.2 Aurobindo Business Overview

11.9.3 Aurobindo Generic Medicine Introduction

11.9.4 Aurobindo Revenue in Generic Medicine Business (2020-2025)

11.9.5 Aurobindo Recent Development

11.10 Lupin

11.10.1 Lupin Company Details

11.10.2 Lupin Business Overview

11.10.3 Lupin Generic Medicine Introduction

11.10.4 Lupin Revenue in Generic Medicine Business (2020-2025)

11.10.5 Lupin Recent Development

11.11 Dr. Reddy's

11.11.1 Dr. Reddy's Company Details

11.11.2 Dr. Reddy's Business Overview

11.11.3 Dr. Reddy's Generic Medicine Introduction

11.11.4 Dr. Reddy's Revenue in Generic Medicine Business (2020-2025)

11.11.5 Dr. Reddy's Recent Development

11.12 Apotex

11.12.1 Apotex Company Details

11.12.2 Apotex Business Overview

11.12.3 Apotex Generic Medicine Introduction

11.12.4 Apotex Revenue in Generic Medicine Business (2020-2025)

11.12.5 Apotex Recent Development

11.13 Cipla

11.13.1 Cipla Company Details

11.13.2 Cipla Business Overview

11.13.3 Cipla Generic Medicine Introduction

11.13.4 Cipla Revenue in Generic Medicine Business (2020-2025)

11.13.5 Cipla Recent Development

11.14 ENDO (Par Pharmaceutical)

11.14.1 ENDO (Par Pharmaceutical) Company Details

11.14.2 ENDO (Par Pharmaceutical) Business Overview

11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Introduction

11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2020-2025)

11.14.5 ENDO (Par Pharmaceutical) Recent Development

11.15 Stada Arzneimittel

11.15.1 Stada Arzneimittel Company Details

11.15.2 Stada Arzneimittel Business Overview

11.15.3 Stada Arzneimittel Generic Medicine Introduction

11.15.4 Stada Arzneimittel Revenue in Generic Medicine Business (2020-2025)

11.15.5 Stada Arzneimittel Recent Development

11.16 Krka Group

11.16.1 Krka Group Company Details

11.16.2 Krka Group Business Overview

11.16.3 Krka Group Generic Medicine Introduction

11.16.4 Krka Group Revenue in Generic Medicine Business (2020-2025)

11.16.5 Krka Group Recent Development

11.17 Nichi-Iko Pharmaceutical

11.17.1 Nichi-Iko Pharmaceutical Company Details

11.17.2 Nichi-Iko Pharmaceutical Business Overview

11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Introduction

11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2020-2025)

11.17.5 Nichi-Iko Pharmaceutical Recent Development

11.18 Valeant

11.18.1 Valeant Company Details

11.18.2 Valeant Business Overview

11.18.3 Valeant Generic Medicine Introduction

11.18.4 Valeant Revenue in Generic Medicine Business (2020-2025)

11.18.5 Valeant Recent Development

11.19 Zydus Cadila

11.19.1 Zydus Cadila Company Details

11.19.2 Zydus Cadila Business Overview

11.19.3 Zydus Cadila Generic Medicine Introduction

11.19.4 Zydus Cadila Revenue in Generic Medicine Business (2020-2025)

11.19.5 Zydus Cadila Recent Development

11.20 Hikma

11.20.1 Hikma Company Details

11.20.2 Hikma Business Overview

11.20.3 Hikma Generic Medicine Introduction

11.20.4 Hikma Revenue in Generic Medicine Business (2020-2025)

11.20.5 Hikma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

TEVA

Novartis (Sandoz)

Mylan NV

Sun Pharmaceutical

Aspen

Fresenius Kabi

Pfizer (Hospira)

Sanofi

Aurobindo

Lupin Ltd

Dr. Reddy's

Apotex

Cipla Ltd

ENDO (Par Pharmaceutical)

Stada Arzneimittel

Krka Group

Nichi-Iko Pharmaceutical

Valeant

Zydus Cadila

Hikma

List of Tables

Table 1. Global Generic Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Simple Generic Drugs

Table 3. Key Players of Super Generic Drugs

Table 4. Key Players of Biosimilars

Table 5. Key Players of By Application:

Table 6. Key Players of CNS

Table 7. Key Players of Cardiovascular

Table 8. Key Players of Respiratory

Table 9. Global Generic Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Generic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Generic Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Generic Medicine Market Share by Region (2020-2025)

Table 13. Global Generic Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Generic Medicine Market Share by Region (2026-2031)

Table 15. Generic Medicine Market Trends

Table 16. Generic Medicine Market Drivers

Table 17. Generic Medicine Market Challenges

Table 18. Generic Medicine Market Restraints

Table 19. Global Generic Medicine Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Generic Medicine Market Share by Players (2020-2025)

Table 21. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Medicine as of 2024)

Table 22. Ranking of Global Top Generic Medicine Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Generic Medicine Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Generic Medicine, Headquarters and Area Served

Table 25. Global Key Players of Generic Medicine, Product and Application

Table 26. Global Key Players of Generic Medicine, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Generic Medicine Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Generic Medicine Revenue Market Share by Type (2020-2025)

Table 30. Global Generic Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Generic Medicine Revenue Market Share by Type (2026-2031)

Table 32. Global Generic Medicine Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Generic Medicine Revenue Market Share by Application (2020-2025)

Table 34. Global Generic Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Generic Medicine Revenue Market Share by Application (2026-2031)

Table 36. North America Generic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Generic Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Generic Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Generic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Generic Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Generic Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Generic Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Generic Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Generic Medicine Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Generic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Generic Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Generic Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Generic Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Generic Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Generic Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 51. Teva Company Details

Table 52. Teva Business Overview

Table 53. Teva Generic Medicine Product

Table 54. Teva Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 55. Teva Recent Development

Table 56. Novartis - Sandoz Company Details

Table 57. Novartis - Sandoz Business Overview

Table 58. Novartis - Sandoz Generic Medicine Product

Table 59. Novartis - Sandoz Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 60. Novartis - Sandoz Recent Development

Table 61. Mylan Company Details

Table 62. Mylan Business Overview

Table 63. Mylan Generic Medicine Product

Table 64. Mylan Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 65. Mylan Recent Development

Table 66. Sun Pharmaceutical Company Details

Table 67. Sun Pharmaceutical Business Overview

Table 68. Sun Pharmaceutical Generic Medicine Product

Table 69. Sun Pharmaceutical Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 70. Sun Pharmaceutical Recent Development

Table 71. Aspen Company Details

Table 72. Aspen Business Overview

Table 73. Aspen Generic Medicine Product

Table 74. Aspen Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 75. Aspen Recent Development

Table 76. Fresenius Kabi Company Details

Table 77. Fresenius Kabi Business Overview

Table 78. Fresenius Kabi Generic Medicine Product

Table 79. Fresenius Kabi Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 80. Fresenius Kabi Recent Development

Table 81. Pfizer (Hospira) Company Details

Table 82. Pfizer (Hospira) Business Overview

Table 83. Pfizer (Hospira) Generic Medicine Product

Table 84. Pfizer (Hospira) Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 85. Pfizer (Hospira) Recent Development

Table 86. Sanofi Company Details

Table 87. Sanofi Business Overview

Table 88. Sanofi Generic Medicine Product

Table 89. Sanofi Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 90. Sanofi Recent Development

Table 91. Aurobindo Company Details

Table 92. Aurobindo Business Overview

Table 93. Aurobindo Generic Medicine Product

Table 94. Aurobindo Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 95. Aurobindo Recent Development

Table 96. Lupin Company Details

Table 97. Lupin Business Overview

Table 98. Lupin Generic Medicine Product

Table 99. Lupin Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 100. Lupin Recent Development

Table 101. Dr. Reddy's Company Details

Table 102. Dr. Reddy's Business Overview

Table 103. Dr. Reddy's Generic Medicine Product

Table 104. Dr. Reddy's Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 105. Dr. Reddy's Recent Development

Table 106. Apotex Company Details

Table 107. Apotex Business Overview

Table 108. Apotex Generic Medicine Product

Table 109. Apotex Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 110. Apotex Recent Development

Table 111. Cipla Company Details

Table 112. Cipla Business Overview

Table 113. Cipla Generic Medicine Product

Table 114. Cipla Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 115. Cipla Recent Development

Table 116. ENDO (Par Pharmaceutical) Company Details

Table 117. ENDO (Par Pharmaceutical) Business Overview

Table 118. ENDO (Par Pharmaceutical) Generic Medicine Product

Table 119. ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 120. ENDO (Par Pharmaceutical) Recent Development

Table 121. Stada Arzneimittel Company Details

Table 122. Stada Arzneimittel Business Overview

Table 123. Stada Arzneimittel Generic Medicine Product

Table 124. Stada Arzneimittel Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 125. Stada Arzneimittel Recent Development

Table 126. Krka Group Company Details

Table 127. Krka Group Business Overview

Table 128. Krka Group Generic Medicine Product

Table 129. Krka Group Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 130. Krka Group Recent Development

Table 131. Nichi-Iko Pharmaceutical Company Details

Table 132. Nichi-Iko Pharmaceutical Business Overview

Table 133. Nichi-Iko Pharmaceutical Generic Medicine Product

Table 134. Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 135. Nichi-Iko Pharmaceutical Recent Development

Table 136. Valeant Company Details

Table 137. Valeant Business Overview

Table 138. Valeant Generic Medicine Product

Table 139. Valeant Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 140. Valeant Recent Development

Table 141. Zydus Cadila Company Details

Table 142. Zydus Cadila Business Overview

Table 143. Zydus Cadila Generic Medicine Product

Table 144. Zydus Cadila Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 145. Zydus Cadila Recent Development

Table 146. Hikma Company Details

Table 147. Hikma Business Overview

Table 148. Hikma Generic Medicine Product

Table 149. Hikma Revenue in Generic Medicine Business (2020-2025) & (US$ Million)

Table 150. Hikma Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Generic Medicine Picture

Figure 2. Global Generic Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Generic Medicine Market Share by Type: 2024 VS 2031

Figure 4. Simple Generic Drugs Features

Figure 5. Super Generic Drugs Features

Figure 6. Biosimilars Features

Figure 7. By Application: Features

Figure 8. CNS Features

Figure 9. Cardiovascular Features

Figure 10. Respiratory Features

Figure 11. Rheumatology Features

Figure 12. Diabetes Features

Figure 13. Global Generic Medicine Market Size by Application (2020-2031) & (US$ Million)

Figure 14. Global Generic Medicine Market Share by Application: 2024 VS 2031

Figure 15. CNS Case Studies

Figure 16. Cardiovascular Case Studies

Figure 17. Respiratory Case Studies

Figure 18. Rheumatology Case Studies

Figure 19. Diabetes Case Studies

Figure 20. Oncology Case Studies

Figure 21. Others Case Studies

Figure 22. Generic Medicine Report Years Considered

Figure 23. Global Generic Medicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 24. Global Generic Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 25. Global Generic Medicine Market Share by Region: 2024 VS 2031

Figure 26. Global Generic Medicine Market Share by Players in 2024

Figure 27. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Medicine as of 2024)

Figure 28. The Top 10 and 5 Players Market Share by Generic Medicine Revenue in 2024

Figure 29. North America Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. North America Generic Medicine Market Share by Country (2020-2031)

Figure 31. United States Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Canada Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Europe Generic Medicine Market Share by Country (2020-2031)

Figure 35. Germany Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. France Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. U.K. Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Italy Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Russia Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Nordic Countries Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Generic Medicine Market Share by Region (2020-2031)

Figure 43. China Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Japan Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. South Korea Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. India Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Australia Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Latin America Generic Medicine Market Share by Country (2020-2031)

Figure 51. Mexico Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Brazil Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Middle East & Africa Generic Medicine Market Share by Country (2020-2031)

Figure 55. Turkey Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. UAE Generic Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Teva Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 59. Novartis - Sandoz Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 60. Mylan Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 61. Sun Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 62. Aspen Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 63. Fresenius Kabi Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 64. Pfizer (Hospira) Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 65. Sanofi Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 66. Aurobindo Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 67. Lupin Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 68. Dr. Reddy's Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 69. Apotex Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 70. Cipla Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 71. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 72. Stada Arzneimittel Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 73. Krka Group Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 74. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 75. Valeant Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 76. Zydus Cadila Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 77. Hikma Revenue Growth Rate in Generic Medicine Business (2020-2025)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Generic Oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Specialty Generics Market

Cancer Generics Market

Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Drugs for Multiple Cancers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Breast Cancer Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Guidewire Market Research Report 2024

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions